Open Government Portal

Open Data Portal Catalogue Dataset
Found 20880 records

A safety review was undertaken soon after the European Medicines Agency notified Health Canada of the possibility that the use …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Hydroxyzine ATARAX assessing potential risk abnormal heart rhythm abnormal changes electrical-activity of the-heart QT interval prolongation

It is known that hydrocodone can slow breathing when too much is taken. The labelling for these drugs already warns …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Hydrocodone-containing products assessing risk slow breathing Serious-Breathing-Problems respiratory depression

Health Canada reviewed the potential risk of liver injury with green tea extract-containing natural health products because of ongoing reports …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Green tea extract natural health products assessing potential risk liver injury hepatotoxicity

The safety of all vaccines, including Gardasil, is under continuous monitoring by Health Canada and the Public Health Agency of …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review GARDASIL all vaccines side-effects after vaccination Quadrivalent Human Papillomavirus Recombinant Vaccine assessing general safety Autoimmune Cardiovascular Diseases body's own-defence-system attacks-itself autoimmune diseases diseases affecting ...

In 2016, Health Canada reviewed the risk of gadolinium build-up in the brain and potential neurological side effects in light …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Gadolinium assessing risk gadolinium build-up brain brain-and-nervous system neurological side effects

In 2014, the product information for gabapentin products was updated to warn about the risk of serious breathing problems (respiratory …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Gabapentin assessing potential risk Serious Breathing Problems respiratory depression used with an-opioid

Health Canada started a safety review following a review done by the FDA on systemic (taken by mouth or by …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Fluoroquinolones assessing risk persistent-and-disabling side effects

This safety review was carried out as a follow-up assessment on the potential risk of suicidality with the use of …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Finasteride assessing risk of Suicidal Suicidal Thoughts-and-Behaviour Suicidality

Health Canada reviewed the risk of potential serious muscle-related side effects with finasteride use because of reports in which these …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review Finasteride assessing potential risk Muscle-Related Side Effects Propecia and Proscar rhabdomyolysis pain in muscles breakdown of muscle-tissue muscle proteins kinase enzymes ...

A safety review was carried out by Health Canada to evaluate the risk of harmful side effects in areas of …

Last Updated: May 7, 2024
Date Published: May 7, 2024
Publisher: Health Canada
Formats: HTML
Keywords: Summary Safety Review EYLEA aflibercept assessing risk of side-effects Outside the Eye systemic side effects systemic toxicity